No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
INBX Inhibrx Biosciences
- 14.490
- +0.020+0.14%
Close Dec 24 13:00 ET
209.76MMarket Cap0.12P/E (TTM)
14.680High13.940Low51.60KVolume13.940Open14.470Pre Close743.35KTurnover0.68%Turnover RatioLossP/E (Static)14.48MShares18.95052wk High1.18P/B110.46MFloat Cap10.80052wk Low--Dividend TTM7.62MShs Float18.950Historical High--Div YieldTTM5.11%Amplitude10.800Historical Low14.405Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing
JMP Securities Maintains Inhibrx Biosciences(INBX.US) With Hold Rating
JMP Securities Sticks to Their Hold Rating for Inhibrx Biosciences Inc (INBX)
The Recent Drop in Prices Must Have Disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) Institutional Investors Who Own 43% of the Shares
Inhibrx Biosciences | 10-Q: Quarterly report
Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.